| Literature DB >> 20653106 |
Jayaprakasam Madhumathi1, Prabhu Rajaiah Prince, Gandhirajan Anugraha, Pote Kiran, Donthamsetty Nageswara Rao, Maryada Venkata Rami Reddy, Perumal Kaliraj.
Abstract
Although multi-epitope vaccines have been evaluated for various diseases, they have not yet been investigated for lymphatic filariasis. Here, we report for the first time identification of two immunodominant B epitopes (TRXP1 and TRXP2) from the antioxidant Brugia malayi thioredoxin by studying their immune responses in mice model and human subjects. TRXP1 was also found to harbor a T epitope recognized by human PBMCs and mice splenocytes. Further, the epitopic peptides were synthesized as a single peptide conjugate (PC1) and their prophylactic efficacy was tested in a murine model of filariasis with L3 larvae. PC1 conferred a significantly high protection (75.14%) (P < 0.0001) compared to control (3.7%) and recombinant TRX (63.03%) (P < 0.018) in experimental filariasis. Our results suggest that multi-epitope vaccines could be a promising strategy in the control of lymphatic filariasis.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20653106 DOI: 10.1016/j.vaccine.2010.05.012
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641